CD8A and melanoma: For example, a study reported that after anti-PD-1 inhibitor treatment in melanoma patients, the frequency of CD8 effector memory T cells in the circulating blood of responders increased, while the frequency of CD4 effector memory T cells and CD8 naive T cells decreased (58).